Clinical Trial Update: Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma [Phase 4]

View source ↗

Summary

An update on a Phase 4 trial evaluating biomarkers in the first-line treatment of metastatic renal cell carcinoma, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Metastatic Renal Cell Carcinoma | Phase 4 | Status: TERMINATED